Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Medical - Pharmaceuticals

Healthcare
$27.69 +1.77%

+$0.52 today

Market cap
$1.23B
Beta
0.00
52W Low $24.15High $32.23

Volume 0.40M

Average 0.51M

AVLN Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

No reported Operating Margin figures are available to summarize.

Operating Margin history

Percent of revenue · from the income statement

No Operating Margin data reported for this period type.

Operating Margin vs competitors

How AVLN compares with its peers on the latest reported figures

AVLN Competitors Peer median
Operating Margin for AVLN and competitors
Company Period LTM level YoY 3-year change
MNKDMannKind CorporationLTM Mar 20263.7% -22.5 pp+75.4 pp
GYREGyre Therapeutics, Inc.LTM Mar 2026-0.1% -10.4 pp+0.9 pp
INSMInsmed IncorporatedLTM Jun 2026-71.9% +180.5 pp-7.7 pp
VCREVicore Pharma Holding ABLTM Jun 2026-21455.4% -8894.6 pp—
AVLNAvalyn Pharma Inc. Common Stock—— ——
Peer median (excluding AVLN) -36.0%-16.5 pp+0.9 pp

Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Intrinsic Alpha fair value

Locked

Current Price

$27.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.